Cell Sheet Engineering from Japan to the World
CellSeed is committed to delivering medical treatments based on cell sheet engineering pioneered in Japan
to patients worldwide in as quick a timeframe as possible.
Our business model
Regenerative medicine is a new kind of medicine for regenerating and curing lost, damaged or deteriorated tissues. Using the outcomes of research at universities as seeds, we conducts clinical trials and develop regenerative medicine products, with the aim of contributing to medicine around the world.
Three basic technologies
1.Cell Sheet Engineering
Cell sheet engineering is a technique for culturing cells in sheets using temperature-responsive cell cultureware. these cell sheets are expected to effectively treat diseases that have proved difficult to address with conventional methods.
Our cell culture equipment uses a temperature-responsive polymer that can recover the sheet of cells cultured without enzyme treatment by changing the temperature.
The UpCell® surface consists of a layer of poly(N-isopropylacrylamide) (PIPAAm) uniformly immobilized at nanometer-scale thickness.
Global business allianceAiming for global expansion of the cell sheet regenerative medicine business
Business Alliance with Taiwanese Company
In 2017, we entered into a business alliance agreement with MetaTech (AP) Inc., an over-the-counter company in Taiwan, aimed at licensing the cell sheet regenerative medicine business in Taiwan. We are currently providing support for the manufacture and development of cell sheets to MetaTech. We also aim to expand the cell sheet regenerative medicine business to Asian countries other than Taiwan as well as Europe and the U.S., and are continuing our efforts directed at business alliances with overseas companies.
Contact us below about CellSeed